Compumedics (ASX:CMP) DeferredTaxAndRevenue : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Compumedics DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Compumedics's current deferred tax and revenue for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Compumedics DeferredTaxAndRevenue Historical Data

The historical data trend for Compumedics's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compumedics DeferredTaxAndRevenue Chart

Compumedics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

DeferredTaxAndRevenue

Get a 7-Day Free Trial

1.39

1.82

2.10

1.92

2.78

Compumedics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
DeferredTaxAndRevenue	Get a 7-Day Free Trial															-	1.92	0.18	2.78	-

Compumedics DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Compumedics's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Compumedics (ASX:CMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Compumedics Ltd (ASX:CMP) » Definitions » DeferredTaxAndRevenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.compumedics.com.au

Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.